Eternity Bioscience,

Eternity Bioscience, Inc. (EBI) is the R&D center founded in 2009 by Hengrui Medicine as its subsidiary located at 6 Cedarbrook Drive, Cranbury New Jersey. EBI research is focusing on the discovery of drug treatment for oncology, immunology, and other diseases. By coupling the biological insights determined from the target selection with structure-guided small molecule design, EBI scientists rapidly advance the small molecule leads to clinical drug candidates. Hengrui Medicine ranks as one of the top 30 pharmaceutical companies worldwide and employs more than 21,000 employees with currently close to 70-billion-dollar market value. Over 3,200 research scientists work in the ten research centers around the globe. As Hengui's New Jersey R&D center, EBI’s mission is to deliver innovative first-in-class and/or best-in-class drug candidates for unmet medical needs.